Biogena

series-c-plus
series-c-plus
Stage
1
Investors

About

Biogena develops and manufactures micronutrient and nutraceutical products (pure-substance formulations) for areas such as anti-aging, sleep and wellbeing, and management of food intolerances. The company is a European reinsubstanz (pure-substance) manufacturer and has financed growth via debt and equity placements on platforms like Invesdor.

Explore Biogena's full profile on Brouky

Funding rounds, investor list, and risk signals — unlock with a subscription.